
ABOUT ADVARRA
Advarra advances the way clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted IRB and IBC review solutions, innovative technologies, experienced consultants, and deep-seated connections across the industry, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance. Advarra is advancing clinical trials to make them safer, smarter, and faster. For more information, visit advarra.com.
BROCHURES
- Streamline Data Collection, Management, And Compliance
- A Clinical Command Center For Efficient, Compliant Research
- Solutions For Health Authority Inspection Readiness And Remediation
- IRB Services For Institutional Sites
- Meeting Compliance Without Compromise
- Advarra University And Training
- Advarra Consulting: Global Consulting Powered By Relevant Experience
- Mitigate Risk With Research Billing Compliance Services
- Cosmetics Research And IRB Review
- Advarra eReg Integrations Overview
- Clinical Research Staffing Solutions
- Support For Institutions
- Advarra Custom Learning Portals
- eConsent Overview
- Elevate Your Research With Comprehensive Tools And Expertise
- Streamline Your Regulatory Process
- Study Startup Support
- Quality Center Of Excellence
- SiteIQ
- Optimize Your Research Administration, Compliance, And Operations
VIDEOS
-
Decentralized clinical trials and the solutions and services that support them are still taking shape in the new research landscape. Learn what they are, how they impact your responsibilities and explore solutions to challenges implementing decentralized clinical trials.
-
In this video, learn why Advarra is trusted by global clinical leaders to enable safety, compliance, & efficiency in their research. Advarra advances human health, by making clinical research safer, smarter, and faster.
-
An institutional biosafety committee (IBC) is a panel of experts that assesses risks associated with gene therapy research to ensure the research is conducted safely and in compliance with the NIH Guidelines. Watch this video to learn what an IBC is and when IBC review is required.
-
We are honored to support a resilient research community during the COVID-19 pandemic. See the data points in our video to find out how Advarra helps keep research moving forward.
NEWS
- Advarra Launches Cloud-Based Secure Document Exchange To Accelerate Study Startup
- Advarra Acquires YourEncore, A Leading Provider Of Drug Development And Commercialization Advisory And Consulting Services
- Advarra Acquires Longboat, A Leading Provider Of Site Training, Protocol Compliance, And Patient Engagement Solutions
- HHS OGC Issues Important Advisory Opinions On The PREP Act
- Advarra Acquires IntegReview IRB
- Advarra Calls Research Sites ‘Unsung Heroes’ Of COVID-19 Crisis
- Science 37® Partners With Advarra To Expedite Virtual Trial Research For COVID-19
- Advarra Joins Leading Healthcare Companies To Announce COVID-19 Research Database
- Advarra Acquires IRBco
- Advarra Announces Appointment Of Gadi Saarony As Chief Executive Officer
- Advarra Technology Keeps Research Moving During COVID-19 Pandemic At Academic Institutions
- Free Research Compliance Resources During COVID-19 Crisis
CONTACT INFORMATION
Advarra
6940 Columbia Gateway Drive, Suite 110
Columbia, MD 21046
UNITED STATES
Phone: 410.884.2900
FEATURED ARTICLES
-
This white paper outlines a standardized method for developing a data strategy that can be tailored to a company's current needs and adapted as those needs evolve.
-
Learn how leveraging comprehensive electronic data capture solutions can be pivotal in ensuring the successful execution of clinical research trials.
-
To gain insight into the public's general perceptions and understanding of clinical research, review the findings from this survey, which encompassed 1,000 randomly selected U.S. residents.
-
Delve into the details of the FDA's "Operation Warp Speed for Rare Diseases" initiative and what sites should do to prepare.
-
To streamline reviews, learn how sponsors can coordinate both IBC and IRB assessments through a vendor offering integrated resources.
-
Delve into fundamental definitions, navigate through the regulatory landscape, and examine common applications of mobile apps in research.
-
Discover ways to bridge the gap between sites and sponsors regarding the Medicare Coverage Analysis (MCA) for industry-sponsored trials to better align expectations on both sides and avoid frustration.
-
Delve into the details of how after receiving proper consulting, this renowned biotech company was able to conduct thorough site inspection readiness activities and receive an accelerated FDA approval.
-
Consider these strategies for overcoming the unique characteristics of oncology research and the challenges researchers must confront to enhance the likelihood of successful drug development.
-
Gene therapy research is exciting and full of promise, but because of the risks involved, it’s also highly regulated, requiring additional oversight by an institutional biosafety committee (IBC). So what’s the difference between an IBC and an IRB?
-
This author provides key insights and guidance to sponsors and sites for mitigating risks and ensuring compliance for a successful U.S. Food and Drug Administration inspection.
-
Explore the key considerations institutions should take into account to best navigate impending CMS changes and what to anticipate for the future of clinical trial enrollment for Medicaid beneficiaries.
-
Utilize this comprehensive guide to better understand reportable incidents and the appropriate channels for communication when unforeseen events arise.
-
Dive into the poll results from 1,000 random U.S. residents for an overview of their general perception and understanding of clinical research.